InvestorsHub Logo
Followers 85
Posts 1581
Boards Moderated 0
Alias Born 06/06/2012

Re: DaubersUP post# 234289

Friday, 07/13/2018 11:04:38 AM

Friday, July 13, 2018 11:04:38 AM

Post# of 403095
re Tapinarof... also note not the best Safety profile
a discontinuation rate of 10% compared to 1% placebo due to AEs

see slide 14

the deal w Dermavant does show $ money $ def being put twd developing later-stage novel nonbiologic PsO treatments

https://pdfs.semanticscholar.org/presentation/85a7/62d022dc27ed0e3feae51c014a108450fe40.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News